503 — Lansen Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeSmall Cap
- HK$750.60m
- HK$527.08m
- $65.56m
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year
Brief: Lansen Pharmaceutical Says HY Profit Attributable $6.8 Mln
Brief: Lansen Pharmaceutical Says Interim Results Expected To Exceed Profit Attributable As Compared With That In Same Period Last Year
Brief: Lansen Pharmaceutical Says To Issue 49.5 Mln Placing Shares At Hk$1.20/Share
Brief: Lansen Pharmaceutical Sees Net Profit For Year To Decrease By 99%
Brief: Lansen Pharmaceutical Unit Enters Shareholders' Loan Deal With CI Biotechnology & Other Co
Brief: Lansen Pharmaceutical's Unit Disposed On-Market Aggregate Of 399,482 Starry Shares
Brief: Lansen Pharmaceutical Says It Disposed An Aggregate Of 399,500 Starry Shares
Brief: Lansen Pharmaceutical Says Group's HY Revenue Expected To Record A Moderate Decrease
Brief: Lansen Pharma Updates On Starry Shares Disposal
Brief: Lansen Pharmaceutical Announces Disposal Of Starry Shares
Brief: Lansen Pharmaceutical FY Profit Attributable US$88.2 Million
Brief: Lansen Updates On Starry Shares Disposal
Brief: Lansen Pharm Says Updates On Disposal Of Starry Shares
Brief: Lansen Pharm Posts HY Profit Attributable US$96.4 MLN
Brief: Lansen Pharmaceutical Says On 23 July, Disposed 424,000 Starry Shares